DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Fountzilas G, Valavanis C, Kotoula V et al.
HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant
epirubicin-based dose-dense sequential chemotherapy.
J Transl Med 2012;
10: 10
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.